Year archive

APTAMER GROUP PLC — 2025 filings

All 49 regulatory filings released by APTAMER GROUP PLC (APTA) in 2025, sourced directly from the official regulator.

49 Filings

2025 Period

2025 filings (49)

Filing	Released	Lang
Aptamer signs licensing agreement with Alphazyme Regulatory Filings	2025-12-23	English
Licensing agreement with Twist Bioscience Regulatory Filings	2025-12-16	English
Results of 2025 Annual General Meeting Declaration of Voting Results & Voting Rights Announcements	2025-11-27	English
AGM Statement AGM Information	2025-11-27	English
Strong contract wins build commercial momentum Regulatory Filings	2025-11-14	English
New contract with top five pharma company Regulatory Filings	2025-11-04	English
Posting of Annual Report and Notice of AGM Report Publication Announcement	2025-11-03	English
Full Year Results for the 12mths to 30 June 2025 Earnings Release FY 2025	2025-10-14	English
New contract with top 10 pharma Regulatory Filings	2025-10-13	English
Notice of Results, Analyst & Investor Presentation Report Publication Announcement	2025-10-10	English
Major top 3 global pharma contract win Regulatory Filings	2025-10-08	English
Investor Event and Presentation Regulatory Filings	2025-09-26	English
New contract with Metir plc Regulatory Filings	2025-09-11	English
Notification of dealings by a director/PDMR Director's Dealing	2025-09-09	English
Therapeutic development agreement with Invizius Regulatory Filings	2025-09-02	English
Block Listing Interim Review Share Issue/Capital Change	2025-08-28	English
Biomarker Discovery Service Launch Regulatory Filings	2025-08-27	English
Update on licensing and development progress Regulatory Filings	2025-08-22	English
Exercise of warrants Share Issue/Capital Change	2025-08-19	English
Holding(s) in Company Major Shareholding Notification	2025-08-18	English
Contract extension with global pharma partner Regulatory Filings	2025-08-18	English
Investor Technical Webinar Report Publication Announcement	2025-08-08	English
Holding(s) in Company Major Shareholding Notification	2025-08-07	English
Holding(s) in Company Major Shareholding Notification	2025-08-05	English
Investor Webinar Regulatory Filings	2025-07-31	English
Trading Update Earnings Release FY 2025	2025-07-31	English
Holding(s) in Company Major Shareholding Notification	2025-07-28	English
Result of General Meeting AGM Information	2025-07-24	English
Additional work commissioned by Unilever Regulatory Filings	2025-07-21	English
Issue of Equity in lieu of Non-Exec Director Fees Share Issue/Capital Change	2025-07-18	English
Holding(s) in Company Major Shareholding Notification	2025-07-09	English
Posting of Circular and Notice of General Meeting Regulatory Filings	2025-07-08	English
Placing to raise £2.0 million Capital/Financing Update	2025-07-04	English
Liver fibrosis breakthrough with Optimer® platform Regulatory Filings	2025-06-30	English
Agreement with global life sciences leader Regulatory Filings	2025-06-25	English
Unilever second Optimer development programme Regulatory Filings	2025-05-30	English
Aptamer Announces New Data at ASGCT Regulatory Filings	2025-05-15	English
Optimer licensing agreements and repeat contracts Regulatory Filings	2025-05-15	English
Alzheimer’s test advanced and royalty agreement Regulatory Filings	2025-05-06	English
Licensing agreed for Optimer as vaccine adjuvant Regulatory Filings	2025-04-30	English
Aptamer Presenting at ASGCT Annual Meeting Regulatory Filings	2025-04-29	English
New Corporate Presentation and Investor Factsheet Report Publication Announcement	2025-04-24	English
Interim Results Earnings Release H1 2025	2025-03-11	English
TR-1: Standard form notification of major holdings Major Shareholding Notification	2025-02-27	English
Block Listing Interim Review Share Issue/Capital Change	2025-02-25	English
Notice of Results and Investor Presentation Report Publication Announcement	2025-02-25	English
Issue of Equity in lieu of Director fees Remuneration Information	2025-01-28	English
Half Year Trading Update Earnings Release H1 2025	2025-01-28	English
Notification of dealings by a director/PDMR Director's Dealing	2025-01-13	English